World-first NHS test offered to patients with blood disorders at Whittington Health

Earlier this week, the NHS introduced a groundbreaking genetic test for patients with inherited blood disorders like sickle cell disorder and thalassaemia. This world-first test aims to reduce the risk of side effects from blood transfusions.

Whittington Health NHS Trust was one of the first Trusts to introduce the testing and roll it out to NHS patients.

The test analyses DNA to find the best-matched blood for transfusions, helping to prevent the development of antibodies after treatment. Such antibodies can lead to delays and reactions during future transfusions.

Whittington Health consultant Haematologist Dr Ryan Mullally was part of the working group overseeing the project. “This [test] was the best part of 10 years' work, involving hundreds of researchers and clinicians and thousands of patients across the world. It will help match blood in a better way and I am excited to roll it out at Whittington Health” Mullally said.

Patients with sickle cell, thalassaemia and transfusion-dependent rare inherited anaemias are encouraged to undergo this test alongside routine blood tests.

Whittington Health Sickle Cell patient Stephanie George was one of the first to receive the test and said “It is so important, and I am glad that medicine and technology is finally catching up".

Both ITV and BBC news crews visited Whittington Hospital to see the test take place and speak with staff and patients. You can view their coverage below: